Delivery Order SPE2DB20D3101-SPE2DB25FRHS5
- Not listed
- The Defense Logistics Agency awarded a $4,156.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This delivery order represents a competitive award with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a pharmaceutical product used in hormone therapy, consistent with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Orgovyx 120 mg tablets (30-count units) valued at $4,156.56 with a firm fixed price structure. This is a non-set-aside contract, indicating the award was made through open competition. The delivery order is expected to be completed by September 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Orgovyx is a...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count unit of use packaging) on July 21, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $2,771.04 by the Defense Logistics Agency for 30 tablets of Orgovyx 120 mg, with an ultimate completion date of September 9, 2025. This is a non-set-aside, competitively awarded contract representing a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company...
- The Defense Logistics Agency awarded a $2,771.04 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for 30 tablets of Orgovyx 120 mg, a prescription medication used in hormone therapy. This is a non-set-aside contract with performance to be completed by August 13, 2025, and fulfillment occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- This delivery order, awarded on July 30, 2025, to AmerisourceBergen Drug Corp supplies 30 tablets of Orgovyx 120 mg under a firm fixed price contract valued at $2,771.04. The award is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 20, 2025, and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order is funded through the Defense agency's Medical Supply Chain and represents a child contract under a...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (30-count units) on September 9, 2025, with completion scheduled for September 30, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a $1,385.52 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Orgovyx 120 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (quantity: 30 units) on September 5, 2025, with completion targeted for September 26, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, a pharmaceutical product for medical supply purposes. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 5, 2025. This award was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRHS5Delivery Order
The Defense Logistics Agency awarded a $2,771.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, with performance completion targeted for May 15, 2025. This non-set-aside award represents a routine pharmaceutical procurement through the Defense Logistics Agency's Medical Supply Chain, with performance to be fulfilled from the contractor's Conshohocken, Pennsylvania facility. Orgovyx is a prescription medication used in hormone treatment applications, consistent with AmerisourceBergen's portfolio of specialized pharmaceutical products supplied to federal healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor serving military and veteran healthcare systems, AmerisourceBergen maintains significant federal contracting capacity to supply brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. The contract supports the Defense Health Agency and other federal healthcare customers, demonstrating the contractor's established capability to meet competitive federal procurement standards for critical medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 4/24/25 |